Reply to: Letter to Roh CK et al. 'Incidence and treatment outcomes of leakage after gastrectomy for gastric cancer: Experience of 14,075 patients from a large volume centre'
- PMID: 34127325
- DOI: 10.1016/j.ejso.2021.06.001
Reply to: Letter to Roh CK et al. 'Incidence and treatment outcomes of leakage after gastrectomy for gastric cancer: Experience of 14,075 patients from a large volume centre'
Keywords: Gastrectomy; Gastric cancer; Incidence; Leakage; Treatment outcomes.
Conflict of interest statement
Declaration of competing interest Dr. WJ Hyung reports receiving research grants from Medtronic and GC Pharma, and is the chief executive officer and a stockholder of Hutom. Dr. Hyung has also provided consultancy services to Ethicon, which are unrelated to the submitted work. All other authors declare no conflicts of interest.
Comment on
-
Incidence and treatment outcomes of leakage after gastrectomy for gastric cancer: Experience of 14,075 patients from a large volume centre.Eur J Surg Oncol. 2021 Sep;47(9):2304-2312. doi: 10.1016/j.ejso.2021.02.013. Epub 2021 Feb 25. Eur J Surg Oncol. 2021. PMID: 33663943
-
Letter to Roh CK et al. 'Incidence and treatment outcomes of leakage after gastrectomy for gastric cancer: Experience of 14,075 patients from a large volume centre'.Eur J Surg Oncol. 2021 Sep;47(9):2468-2469. doi: 10.1016/j.ejso.2021.06.002. Epub 2021 Jun 5. Eur J Surg Oncol. 2021. PMID: 34112561 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
